Are you a patient or survivor of a pediatric or young adult cancer? You may be able to take part in this registry to help us learn about long-term and treatment-related adverse outcomes.

Have you been recently diagnosed with Diffuse Large B Cell Lymphoma? Are you over 75 years of age? If so, you may be able to take part in a research study looking at the safety of giving a new study drug CC-486 (oral azacitidine) in addition to the standard chemotherapy drug combination used to treat this disease.

Do you have cancer? Are you about to start immunotherapy? You may be able to participate in a research study to help answer many questions that still exist about immunotherapy like - Who is more likely to get side effects? What treatments will help control the side effects but let patients continue their cancer treatment? What factors can affect the type of side effects patients have (type of cancer or immunotherapy? previous chemo or radiation? existing autoimmune diseases?, etc.) and more.

Do you have mantle cell lymphoma or other non-Hodgkin lymphoma that has either come back or did not get better with your last treatment? If so, you may be able to take part in a study that will modify your own immune cells to see if it may treat your cancer.

Have you been diagnosed with central nervous system (CNS) lymphoma? Have you received treatment for this disease, but it either came back or did not improve? Then you may be eligible to participate ind a study to look at the safety and effectiveness of the new study drug acalabrutinib.

Are you living with Metastatic or Advanced Cancer? Are you interested in having a personal health coach to help you set healthy lifestyle goals? Your personal health coach would prescribe cardio and strength training exercises, help you monitor symptoms, and navigate you to supportive care. If you have cancer and are receiving care at UNC Cancer Center, you may be able to participate.

Do you have Peripheral T Cell Lymphoma? Has your cancer come back or did it not get better with the last treatment you were given? If so, you may be eligible to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

Do you have Hodgkin's Lymphoma that has either come back or did not get better after CAR-T therapy? If so, you may be able to take part in a study that will use anti-PD-1 therapy to treat your cancer.

Have you been diagnosed with B-Cell Lymphoma? Are you looking for options to treat your cancer? If so, you may be able to take part in a research study looking at the safety of giving a new drug called iC9-CAR19 with Rimiducid.

Do you have Hodgkin's Lymphoma, or Cutaneous T-Cell Lymphoma? Has your lymphoma come back, or did not get better after your last treatment? If so, you might be able to take part in a study that will modify your own immune cells to see if it may treat your lymphoma.